These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. ALS Genes in the Genomic Era and their Implications for FTD. Nguyen HP; Van Broeckhoven C; van der Zee J Trends Genet; 2018 Jun; 34(6):404-423. PubMed ID: 29605155 [TBL] [Abstract][Full Text] [Related]
28. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity. Benatar M; Granit V; Andersen PM; Grignon AL; McHutchison C; Cosentino S; Malaspina A; Wuu J Brain; 2022 Oct; 145(10):3500-3508. PubMed ID: 35594156 [TBL] [Abstract][Full Text] [Related]
29. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. Ruffini N; Klingenberg S; Schweiger S; Gerber S Cells; 2020 Dec; 9(12):. PubMed ID: 33302607 [TBL] [Abstract][Full Text] [Related]
31. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis. Mulligan VK; Chakrabartty A Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986 [TBL] [Abstract][Full Text] [Related]
32. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. Millecamps S; Salachas F; Cazeneuve C; Gordon P; Bricka B; Camuzat A; Guillot-Noël L; Russaouen O; Bruneteau G; Pradat PF; Le Forestier N; Vandenberghe N; Danel-Brunaud V; Guy N; Thauvin-Robinet C; Lacomblez L; Couratier P; Hannequin D; Seilhean D; Le Ber I; Corcia P; Camu W; Brice A; Rouleau G; LeGuern E; Meininger V J Med Genet; 2010 Aug; 47(8):554-60. PubMed ID: 20577002 [TBL] [Abstract][Full Text] [Related]
33. Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations. Maestro I; de la Ballina LR; Porras G; Corrochano S; De Lago E; Simonsen A; Boya P; Martinez A Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293534 [TBL] [Abstract][Full Text] [Related]
34. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. Liu KX; Edwards B; Lee S; Finelli MJ; Davies B; Davies KE; Oliver PL Brain; 2015 May; 138(Pt 5):1167-81. PubMed ID: 25753484 [TBL] [Abstract][Full Text] [Related]
35. Hot-spot KIF5A mutations cause familial ALS. Brenner D; Yilmaz R; Müller K; Grehl T; Petri S; Meyer T; Grosskreutz J; Weydt P; Ruf W; Neuwirth C; Weber M; Pinto S; Claeys KG; Schrank B; Jordan B; Knehr A; Günther K; Hübers A; Zeller D; Kubisch C; Jablonka S; Sendtner M; Klopstock T; de Carvalho M; Sperfeld A; Borck G; Volk AE; Dorst J; Weis J; Otto M; Schuster J; Del Tredici K; Braak H; Danzer KM; Freischmidt A; Meitinger T; Strom TM; Ludolph AC; Andersen PM; Weishaupt JH; Brain; 2018 Mar; 141(3):688-697. PubMed ID: 29342275 [TBL] [Abstract][Full Text] [Related]
36. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541 [TBL] [Abstract][Full Text] [Related]
37. The genetics and neuropathology of amyotrophic lateral sclerosis. Al-Chalabi A; Jones A; Troakes C; King A; Al-Sarraj S; van den Berg LH Acta Neuropathol; 2012 Sep; 124(3):339-52. PubMed ID: 22903397 [TBL] [Abstract][Full Text] [Related]
38. Modelling amyotrophic lateral sclerosis: progress and possibilities. Van Damme P; Robberecht W; Van Den Bosch L Dis Model Mech; 2017 May; 10(5):537-549. PubMed ID: 28468939 [TBL] [Abstract][Full Text] [Related]
39. Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Bouscary A; Quessada C; René F; Spedding M; Turner BJ; Henriques A; Ngo ST; Loeffler JP Semin Cell Dev Biol; 2021 Apr; 112():82-91. PubMed ID: 33160824 [TBL] [Abstract][Full Text] [Related]
40. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders. Gascon E; Gao FB J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]